13:52

Ellen Border Perspective - World Cancer Research Day

01:05:11

Update on Adaptimmune's SURPASS Family of Trials

03:15

Amy Sauer, answers our questions for British Science Week 22

02:00:38

Adaptimmune's Symposium at CTOS 2021– “Spotlight on Synovial Sarcoma; Where are we now? Where next?”

53:30

REPLAY of Adaptimmune’s First Live Virtual Event – Our Allogeneic Platform

19:24

Adaptimmune reports updated SURPASS data at ESMO 2021

03:53

Dennis Williams, SVP Late Stage Development, reflects on Sarcoma Awareness Month.

03:39

Adaptimmune's allogeneic or 'off-the-shelf' cell therapies.

00:43

More colleagues take part in Wear White Day 2021

02:17

Adaptimmune Wear White Video 2021

07:44

E. Norry & D. Williams present initial data from SPEARHEAD-1 trial

04:23

Karen Miller, SVP Clinical Pipeline talks about the HiT Platform.

05:26

Adaptimmune ASGCT 2021

09:35

AACR Annual Virtual Meeting 2021 - Focus on our SURPASS and ADP-A2AFP trials

40:18

Adaptimmune Presentation at 39th Annual J.P. Morgan Healthcare Conference

03:22

Our Research: A Rich Cell Therapy Pipeline for the Future

03:48

Manufacturing at Adaptimmune

08:42

SITC 2020 - Adaptimmune's SURPASS Poster

02:21

SPEARHEAD-2 trial design: combining SPEAR T-cells with pembrolizumab

02:17

Mecanismo de Acción del ADP-A2M4CD8 (SPEAR-T cell de próxima generación)

07:48

ADP-A2AFP data presented at the 2020 International Liver Congress

01:12

More Adaptimmune colleagues support the CRI's Wear White Day 2020

01:11

Adaptimmune supports the CRI's Wear White Day 2020

15:48

ASCO Data and Clinical Update: 29 May 2020

01:32

ADP-A2M4CD8 Mechanism of Action (Next-generation SPEAR T-cell)

13:30

SPEAR T-cells Derived from Stem Cells Kill Cancer Targets in vitro - data from ASGCT 2020

01:00

Medical Need for People with Synovial Sarcoma

02:11

Comment nos cellules SPEAR T fonctionnent

02:11

Le parcours du patient

02:13

Cómo funcionan nuestras células SPEAR T

02:11

Viaje de un paciente tratado con nuestras células SPEAR T

01:35

Adaptimmune proudly supports the CRI's Wear White for a Future #Immune2Cancer

02:58

Erin Van Winkle on why putting patients first matters so much to her

03:20

Fran Brophy on why she is passionate about working with our clinical sites

01:56

Jo Brewer summarizes the allogeneic program data she presented at ASGCT 2019

02:28

Jo Brewer talks about our off-the-shelf SPEAR T-cell program

02:53

Adaptimmune SPEAR T-Cell Mechanism of Action Video

01:59

How Cancer Patients get Treated with our SPEAR T-Cells

02:01

How Our SPEAR T-cells Work